1. Early achievement of measurable residual disease negativity in the treatment of multiple myeloma as predictor of outcome. (11th March 2022) Authors: Baumelou, Marion; Payssot, Alexandre; Row, Celine; Racine, Jessica; Lafon, Ingrid; Bastie, Jean‐Noél; Chevreux, Steeve; Chrétien, Marie‐Lorraine; Maynadié, Marc; Caillot, Denis; Guy, Julien Journal: British journal of haematology Issue: Volume 197:Number 6(2022) Page Start: e82 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Is It Time to Include CT "Reverse Halo Sign" and qPCR Targeting Mucorales in Serum to EORTC-MSG Criteria for the Diagnosis of Pulmonary Mucormycosis in Leukemia Patients?. (8th November 2016) Authors: Caillot, Denis; Valot, Stéphane; Lafon, Ingrid; Basmaciyan, Louise; Chretien, Marie Lorraine; Sautour, Marc; Millon, Laurence; Legouge, Caroline; Payssot, Alexandre; Dalle, Frédéric Journal: Open forum infectious diseases Issue: Volume 3:Number 4(2016) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Safety of ninety-minute daratumumab infusion. (July 2021) Authors: Lombardi, Jeffrey; Boulin, Mathieu; Devaux, Madeline; Cransac, Amélie; Pistre, Pauline; Pernot, Corinne; Payssot, Alexandre; Lafon, Ingrid; Caillot, Denis; Gueneau, Pauline Journal: Journal of oncology pharmacy practice Issue: Volume 27:Number 5(2021) Page Start: 1080 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗